Astrana Health (NASDAQ:ASTH) Issues Quarterly Earnings Results, Misses Expectations By $0.37 EPS

Astrana Health (NASDAQ:ASTH) issued its earnings results on Thursday. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37), Zacks reports. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. Astrana Health updated its FY 2025 guidance to EPS.

Astrana Health Trading Down 1.2 %

NASDAQ ASTH opened at $34.68 on Friday. The company has a market capitalization of $1.95 billion, a PE ratio of 26.68, a P/E/G ratio of 1.37 and a beta of 1.20. The stock has a 50-day simple moving average of $35.01 and a 200 day simple moving average of $44.72. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health has a 12 month low of $29.08 and a 12 month high of $63.20.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Truist Financial cut their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Robert W. Baird raised their price target on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. Finally, Stifel Nicolaus lowered their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $65.60.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.